Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,727 JPY | -1.93% | -1.37% | -8.87% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company returns high margins, thereby supporting business profitability.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.2 times its estimated earnings per share for the ongoing year.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.87% | 65.97M | - | - | |
-7.38% | 177B | C+ | ||
-0.46% | 108B | C | ||
-6.98% | 65.55B | A | ||
+2.65% | 50.66B | B- | ||
+5.27% | 42.58B | B- | ||
+5.73% | 40.74B | B+ | ||
+19.92% | 31.07B | B | ||
+16.57% | 25.45B | A- | ||
-7.00% | 23.85B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3446 Stock
- Ratings JTEC Corporation